Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. 2005

Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
Program of Cancer and Developmental Therapeutics, Buck Institute for Age Research, 8001 Red-wood Blvd., Novato, CA 94945, USA.

The vitamin K analog menadione (K3), capable of both redox cycling and arylating nucleophilic substrates by Michael addition, has been extensively studied as a model stress-inducing quinone in both cell culture and animal model systems. Exposure of keratin 8 (k-8) expressing human breast cancer cells (MCF7, T47D, SKBr3) to K3 (50-100 microM) induced rapid, sustained, and site-specific k-8 serine phosphorylation (pSer73) dependent on signaling by a single mitogen activated protein kinase (MAPK) pathway, MEK1/2. Normal nuclear morphology and k-8 immunofluorescence coupled with the lack of DNA laddering or other features of apoptosis indicated that K3-induced cytotoxicity, evident within 4 h of treatment and delayed but not prevented by MEK1/2 inhibition, was due to a form of stress-activated cell death known as oncosis. Independent of MAPK signaling was the progressive appearance of K3-induced cellular fluorescence, principally nuclear in origin and suggested by in vitro fluorimetry to have been caused by K3 thiol arylation. Imaging by UV transillumination of protein gels containing nuclear extracts from K3-treated cells revealed a prominent 17-kDa band shown to be histone H3 by immunoblotting and mass spectrometry (MS). K3 arylation of histones in vitro followed by electrospray ionization-tandem MS analyses identified the unique Cys110 residue within H3, exposed only in the open chromatin of transcriptionally active genes, as a K3 arylation target. These findings delineate new pathways associated with K3-induced stress and suggest a potentially novel role for H3 Cys110 as a nuclear stress sensor.

UI MeSH Term Description Entries
D007633 Keratins A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION. Cytokeratin,Keratin Associated Protein,Keratin,Keratin-Associated Proteins,alpha-Keratin,Associated Protein, Keratin,Keratin Associated Proteins,Protein, Keratin Associated,alpha Keratin
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053533 Keratin-8 A type II keratin found associated with KERATIN-18 in simple, or predominately single layered, internal epithelia. Cytokeratin 8,Cytokeratin-8,Endo-A Cytokeratin,Cytokeratin, Endo-A,Endo A Cytokeratin,Keratin 8

Related Publications

Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
April 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
March 2001, Cancer,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
May 1954, Canadian journal of biochemistry and physiology,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
January 1957, Biochimica et biophysica acta,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
January 2008, Anticancer research,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
September 1991, Archivos latinoamericanos de nutricion,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
December 1995, Archivos latinoamericanos de nutricion,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
September 1977, Journal of chromatography,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
November 1992, Molecular pharmacology,
Gary K Scott, and Christian Atsriku, and Patrick Kaminker, and Jason Held, and Brad Gibson, and Michael A Baldwin, and Christopher C Benz
May 2001, Oncogene,
Copied contents to your clipboard!